🧪Engineering perspectives on cost-cutting in cosmetics and food industries could also be beneficial.
💰Emerging therapies like CAR-T are expensive due to production costs.
🔬Methods that work on a small scale can fail at the industrial scale, wasting time and money.
⚙️Schulze emphasizes the importance of considering scale-up from the beginning and performing techno-economic analysis.
⏱️Factors like power consumption and material selection are often overlooked in pharmaceutical manufacturing.
📉These cost-cutting techniques could be especially valuable for biosimilars that need to be cheaper than branded drugs.
Introduction:
Biomanufacturing consultant Joachim Schulze, PhD, CTO of the Planetary Group, believes that engineering insights can benefit companies in the pharmaceutical industry looking to cut costs in large-scale manufacturing. In an upcoming conference, Schulze will address the importance of adopting an engineering perspective when scaling up new technologies.
- Applying engineering perspectives on cost-cutting in the cosmetics and food industries to the pharmaceutical industry could be beneficial.
- Methods that work in the laboratory often fail at the industrial scale, leading to wasted time and money.
- Consideration of scalability should start from the beginning of product development to avoid detours.
- Techno-economic analysis should be conducted early on to identify inefficiencies that become costly as the product scales up.
- Factors such as expensive nutrients, specialized alloy requirements, and power consumption need to be accounted for in pharmaceutical manufacturing to reduce costs.
Conclusion:
By adopting an engineering perspective, biomanufacturers in the pharmaceutical industry can identify and address inefficiencies that contribute to high costs. Considering scalability from the outset and conducting techno-economic analyses can lead to more cost-effective manufacturing processes. The application of engineering insights from the cosmetics and food industries could also prove beneficial in pharmaceutical manufacturing.
